Seqirus Quadrivalent Influenza Vaccine (QIV)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Seqirus Quadrivalent Influenza Vaccine (QIV), covering 2017-04-18 to 2017-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age [Phase 3]